CHAMEDITECH participated in the IMCAS World Congress 2023 held in Paris, France, from January 26 to January 28.

IMCAS(International Master Course on Aging Science ASIA) is one of the world's top3 aesthetic surgery societies where experts from all over the world participate to exchange the latest academic and technology, for this time at the IMCAS 2023, more than 14,000 industry officials attended to communicate and talk about aesthetic surgery.

CHAMEDITECH held a symposium on HyaFilia, its representative hyaluronic acid filler product, under the topic of 'Facial Sculping with HyaFilia', at IMCAS 2023.

The symposium began with a lecture by Russian dermatologist Dr. Anastasia MASHKINA on the topic of 'Unique correction protocol: Cheekbones, chin and mandible angle as central patterns of youth', drew attention from many medical staff and industry officials interested in the relevant indications.

Dr. Exequiel ORTIZ MIDDLETON, director of the Aesthetic Elite Academy of Chile, who was the speaker of the second lecture, introduced how to use the HyaFilia for product's superior effectiveness is maximized effective on the topic of 'Advanced full face : from evidence to clinical practice with HyaFilia'.

Through this IMCAS 2023, CHAMEDITECH not only introduced HyaFilia's superiority, effective and correct use, but also high safety due to increased physical crosslinking rate and minimized chemical crosslinking substance BDDE, that are based on the technology of CHA-HEART (Cross-linked Hyaluronic Acid of Hight concentration Emulsion Arrangement & Refinement Technology).

CHAMEDITECH, which won the $3 million export tower on the 59th Trade Day in December, will continue to communicate with medical staff and officials around the world about its own biological materials and hyaluronic acid fillers to meet its reputation as a “Global Bio Aesthetics Company”.